(Q34033291)

30 July 2017

1 reference

title

Can axillary dissection be avoided by improved molecular biological diagnosis? (English)

1 reference

30 July 2017

1

Lindahl T

1 reference

30 July 2017

Engel G

2

1 reference

30 July 2017

Ahlgren J

3

1 reference

30 July 2017

Klaar S

4

1 reference

30 July 2017

Bjöhle J

5

1 reference

30 July 2017

Lindman H

6

1 reference

30 July 2017

Andersson J

7

1 reference

30 July 2017

von Schoultz E

8

1 reference

30 July 2017

Bergh J

9

1 reference

30 July 2017

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

39

1 reference

30 July 2017

319-326

1 reference

30 July 2017

3

1 reference

Assessment of morbidity from complete axillary dissection

30 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Axillary dissection: when and how radical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

The metastatic phenotype--prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Correlation between stromelysin-3 mRNA level and outcome of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Fibrinolytic pathways and the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Type-1 plasminogen activator inhibitor in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F028418600750013087

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Prognostic significance of microvessel density in lymph node negative breast carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Microvessel quantitation and prognosis in invasive breast carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Evidence for a novel gene associated with low tumor metastatic potential

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

The effect of pre- and postmastectomy radiotherapy on the degree of edema, shoulder-joint mobility, and gripping force

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Immunohistochemical detection of estrogen receptor in invasive human breast cancer: correlation with heat shock proteins, pS2 and oncogene products

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Lymphatic mapping and sentinel lymphadenectomy for breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

c-erbB2 expression in correlation to other biological parameters of breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

International Consensus Panel on the treatment of primary breast cancer. V: Update 1998.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/028418600750013087

Identifiers

DOI

10.1080/028418600750013087

1 reference

30 July 2017

1 reference